After Britain, Bahrain has become the second country in the world to have formally approved the emergency use of the Covid-19 vaccine developed by pharmaceutical manufacturer Pfizer and its German partner Bioentech. Bahrain’s official communications agency announced this on Friday night.
“After thorough analysis and review of the available data, Bahrain’s Health Regulatory Agency has approved its emergency use,” the agency said. However, Bahrain did not say how many doses of the vaccine she had purchased and when the vaccination would begin. The Bahrain authorities did not immediately respond to an Associated Press question.
Pfizer later reported that the sale agreement, including the supply of the vaccine to Bahrain and the number of doses, was secret and declined to comment. The company said that we have developed a detailed logistic plan regarding the correct transportation, storage and temperature of the vaccine.
However, high temperatures can pose a challenge even after the company’s preparations. Because to store this vaccine produced by Pfizer-BioNotech, a temperature of -70 degrees will be required. At the same time, the weather in the country is generally dry and hot. Significantly, Bahrain has already approved the emergency use of China-made vaccine ‘Sinopharm’ and has so far administered these vaccines to 6,000 people.
At the same time, the global pharmaceutical company Pfizer said on Thursday that it is committed to working with the Government of India to make Pfizer or Bioentech vaccine available in India. A Pfizer spokesperson said in a statement, “We are currently in the process of negotiating with several governments.” We are also committed to working with the Government of India to make the vaccine available in India.
Pfizer said that everyone has the opportunity to access the vaccine. In particular, she is working with governments. “In times of pandemics, Pfizer will provide this vaccine only through government contracts,” the statement said.
Significantly, Britain has become the first country in the world to approve the accidental use of Pfizer or BioNotech vaccines. The UK drug regulator Medicines and Healthcare Products Regulatory Agency (MHRA) has given temporary approval to the company’s vaccine. The vaccine will be available in the UK from next week.